Q-REstrain (SOT Therapy): What It Is, How It Works, and Who It’s For

A complete guide to gene-targeted therapy for Lyme disease, cancer, and chronic viral infections.

Published by Health & Wellness of Carmel

You saw the post. You typed “SOT.” That means you’re curious — and we’re glad you are. Q-REstrain is one of the most significant therapies we offer at Health & Wellness of Carmel, and it deserves a real explanation. Here’s everything you need to know.

What Is Q-REstrain?

Q-REstrain — formerly known as SOT (Supportive Oligonucleotide Therapy) — is an autologous, gene-targeted therapy developed by RGCC (Research Genetic Cancer Centre Group). It uses a branch of molecular biology called RNA interference (RNAi) to silence the specific genes that keep harmful cells — whether cancer cells, bacteria, or viruses — alive and functioning.

In plain language: your own blood is used to create a custom molecule designed to find your specific pathogen or cancer cells and shut them down at the genetic level. It’s not a drug. It’s not a generic supplement. It’s built from you, for you.

Most treatments manage the disease. Q-REstrain is designed to end it.

How It Works: The Key & Lock

Think of your pathogen — whether it’s Lyme, a virus, or a cancer cell — as having a lock. A very specific lock. Q-REstrain works by creating a molecular key that fits that lock exactly, binding to the gene responsible for its survival and switching it off.

Once infused, the molecule circulates through your body continuously, binding to the target gene and inhibiting the proteins essential for the pathogen’s or cancer cell’s survival. It also crosses the blood-brain barrier — something many antibiotics and conventional treatments cannot do.

Blood draw for Q-REstrain — 15–30ml is all that’s needed to create your personalized therapy.

Who Is Q-REstrain For?

CANCER

Q-REstrain can be used for patients with solid tumors or hematological malignancies, regardless of disease stage. It is designed to work alongside conventional treatments and does not interfere with most other therapies when properly timed. Patients must be at least 11 years old; CNS (brain) cancers are not currently eligible.

LYME DISEASE & CO-INFECTIONS

For patients with chronic Lyme who have cycled through antibiotics without full resolution, Q-REstrain offers a fundamentally different approach — not suppression, but gene-level silencing. It targets a wide range of Lyme-related pathogens including:

VIRAL INFECTIONS

Q-REstrain can target many common and persistent viruses including:

The Clinical Data

2022 CLINICAL OUTCOMES

What to Expect

BEFORE YOUR INFUSION

To ensure accurate targeting, you’ll need to pause certain therapies before your blood draw — typically 14 days for Lyme/viral, 14–21 days for cancer patients. This includes antibiotics, antivirals, IV vitamin C, and ozone therapy. You’ll also need positive lab confirmation of your target pathogen within the past 6 months.

THE INFUSION

Done right here at our clinic. You’ll receive a saline IV line, pre-medications (dexamethasone is standard; famotidine and acetaminophen are typically included), then the Q-REstrain itself as a slow IV push. You’re monitored for 45–60 minutes, then free to go.

AFTER THE INFUSION

Most patients resume normal activities the same day. Mild fatigue, headache, or flu-like symptoms can occur — often a sign the therapy is working. Routine supplements (multivitamins, vitamin D, probiotics, glutathione, binders) continue without interruption. Most other therapies resume within 7–14 days.

HOW OFTEN?

Cancer: Up to 4 infusions per year, spaced at least 3 months apart.

Lyme & Viral: Up to 9 infusions per year, spaced at least 21 days apart.

Is Q-REstrain Right for You?

Could Q-REstrain be part of your healing path?

The first step is a consultation at Health & Wellness of Carmel. We’ll review your labs, history, and current treatment plan together.

Visit hwofc.com to Learn More